Warning Label Final Guidance Recommends Use Of Numeric Adverse Reaction Rates
This article was originally published in The Pink Sheet Daily
Executive Summary
Also, known or possible hypersensitivity reactions should be listed under contraindications in drug labeling, FDA says in final guidance.
You may also be interested in...
'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says
US guidances will be shorter and use a series of bullet points to communicate key ideas, replacing the current longer and wordier format.
FDA Highlights Tightened Drug Safety Criteria For Professional Labeling
The labeling rule “is not just a format revision. It is also a content revision,” Deputy Commissioner Woodcock says.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.